PLTR is framed as a long-term compounder still down 11% over 12 months, with 157 net dollar retention, $6.2B trailing revenue, 93% growth, 240% operating growth, and forward P/E compressed from 76 to 53. The immediate setup hinges on the next quarter: current guidance is $2.164B, consensus is $2.18B and $0.41 EPS, and a short-term pop requires guidance raise, consensus beat, and acceleration from 93% growth to 94%+ — otherwise even a beat can still fade 5% to 15%. The valuation case escalates from a prior $18.89 2023 X post to a floor at $495, a base case at $717, and a bull case at $978, yielding the new $1,000 target and implying 431% upside only if the business keeps compounding into 2030. The main risks and watch items are client concentration, >85% of revenue from the US, international expansion into Europe, and stock-based compensation still at 13.7% of revenue.
PLTR is down 11% over the past 12 months despite 157 net dollar retention, described as the highest in the stock market.
PLTR posted $4.5B revenue in 2025 and $6.2B revenue over the past 12 months, with 93% YoY revenue growth, 240% operating growth, and 57% cash growth.
PLTR forward P/E fell from 76 to 53 since last year.
2026 full-year guidance is $8.15B; the quarter’s current guidance is $2.164B revenue, up 83%, versus consensus of $2.18B revenue and $0.41 EPS.
A short-term post-earnings rise needs three conditions at once: guidance raised and beaten, consensus beaten, and acceleration; that means revenue growth must rise from 93% to 94%+.
A short-term spike is modeled only if the quarter prints $2.28B revenue; otherwise even a beat can still see PLTR fall 5%, 10%, or 15% after earnings.
Q2 2026 revenue was $1.93B, up 93%; US commercial revenue grew 149%, operating margin reached 62% from 46%, free cash flow was 63%, cash was $9.5B, and debt was zero.
Q2 2026 operating expenses grew 34% versus 93% revenue growth, so revenue was growing three times faster than opex; the cited rule of 40 metric was 156.
Stock MVP scored PLTR 98/100, missing 2 points only because institutional ownership is still 2% short of the level needed for 100.
The stated weaknesses are client concentration, too much revenue tied to a few oversized contracts, and too much dependence on the US, where more than 85% of money made comes from; Europe/international expansion remains a priority.
Stock-based compensation fell from 16% to 13.7% of revenue but still needs to get into the single digits.
Earnings targets include $950M US commercial revenue, $3.6B full-year commercial revenue to keep growth on track, $2.5B Q4 revenue, $2.13B US commercial total contract value, $6.24B remaining deal value, and higher net dollar retention and rule of 40.
A 2023 X post put PLTR at $18.89 and said the stock was already 10x that level despite the later 11% drawdown over the past year.
The valuation ladder runs from a floor case of $495 using 90/85/80% growth steps, 38% net margin, and 35 P/E; to a base case of $717 using 95/90/85/80% growth steps, 42% net margin, and 45 P/E; to a bull case of $978 using the same growth path, 46% net margin, and 55 P/E in 2030.
The new bull target is $1,000 per share, implied as 431% upside from here; the trading rule into earnings is never buy or sell, keep DCAing, and ignore the stock price.